Abstract
Patients with triple negative breast cancer were identified using the Surveillance, Epidemiology, and End Results database. Competing risks analysis was used to assess the cumulative incidence of breast cancer-specific mortality (BCSM). Multivariable Fine-Gray regression was used to identify predictors of BCSM. Women age 70+ (n = 4221) were less likely to receive chemotherapy and radiation treatment (P < 0.0001) and had higher BCSM compared to younger women (P < 0.0001). There were no differences in BCSM in patients who received adjuvant treatment (P = 0.10). Stage II patients derived the greatest relative and absolute benefit from adjuvant treatment. Age was not a significant predictor of BCSM.
Original language | English (US) |
---|---|
Pages (from-to) | 469-473 |
Number of pages | 5 |
Journal | Breast Journal |
Volume | 25 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2019 |
Externally published | Yes |
Keywords
- breast cancer
- chemotherapy
- outcomes
- radiation treatment
- triple negative
ASJC Scopus subject areas
- Internal Medicine
- Surgery
- Oncology